Literature DB >> 3491775

The economic burden of depression.

A Stoudemire, R Frank, N Hedemark, M Kamlet, D Blazer.   

Abstract

This article provides estimates of direct treatment costs and indirect costs from lost productivity associated with the morbidity and mortality of depression. Data are based on epidemiologic estimates of the prevalence of major depressive illness and on the number of suicides assumed to be secondary to depression. The number of hospitalizations, hospital days, physician and mental health provider visits, home/nursing home costs, and pharmaceutical costs are estimated. The direct and indirect costs are estimated to be approximately $16.3 billion per year. These economic figures provide a lower-bound estimate of the full economic burden of major depression and further emphasize the need for timely recognition and treatment to potentially minimize the negative impact of the illness on society.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3491775     DOI: 10.1016/0163-8343(86)90018-6

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  48 in total

1.  Initial treatment choice in depression: impact on medical expenditures.

Authors:  E T Edgell; T R Hylan; J R Draugalis; S J Coons
Journal:  Pharmacoeconomics       Date:  2000-04       Impact factor: 4.981

2.  Effects of Iraq/Afghanistan deployments on major depression and substance use disorder: analysis of active duty personnel in the US military.

Authors:  Yu-Chu Shen; Jeremy Arkes; Thomas V Williams
Journal:  Am J Public Health       Date:  2012-01-25       Impact factor: 9.308

3.  Crisis, suicide and labour productivity losses in Spain.

Authors:  Berta Rivera; Bruno Casal; Luis Currais
Journal:  Eur J Health Econ       Date:  2016-01-22

4.  Lithium revisited: savings brought about by the use of lithium, 1970-1991.

Authors:  R J Wyatt; I D Henter; J C Jamison
Journal:  Psychiatr Q       Date:  2001

5.  Depression in primary care: assessing suicide risk.

Authors:  Chung Wai Mark Ng; Choon How How; Yin Ping Ng
Journal:  Singapore Med J       Date:  2017-02       Impact factor: 1.858

6.  Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism.

Authors:  Francis E Lotrich; Robert E Ferrell; Mordechai Rabinovitz; Bruce G Pollock
Journal:  Biol Psychiatry       Date:  2008-09-18       Impact factor: 13.382

Review 7.  Defining and measuring functional recovery from depression.

Authors:  Tracy L Greer; Benji T Kurian; Madhukar H Trivedi
Journal:  CNS Drugs       Date:  2010-04       Impact factor: 5.749

Review 8.  Periodic health examination, 1990 update: 2. Early detection of depression and prevention of suicide. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1990-06-01       Impact factor: 8.262

Review 9.  The economic burden of depression and the cost-effectiveness of treatment.

Authors:  Philip S Wang; Gregory Simon; Ronald C Kessler
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

Review 10.  Behavioural toxicity of antidepressants with particular reference to moclobemide.

Authors:  I Hindmarch; J Kerr
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.